Quick Answer
Clearside Biomedical, Inc. reported Cash And Cash Equivalents At Carrying Value of $20.02 million for the year ending 2024.
- Clearside Biomedical, Inc. showed a decrease of -30.8% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
- This data is from Clearside Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2013 to 2024 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: $7.33 million | Q3 2015: $4.19 million | Q1 2016: $15.89 million | Q2 2016: $55.28 million | Q3 2016: $36.88 million | Q1 2017: $22.99 million | Q2 2017: $16.68 million | Q3 2017: $16.29 million | Q1 2018: $84.83 million | Q2 2018: $35.19 million | Q3 2018: $15.84 million | Q1 2019: $32.95 million | Q2 2019: $26.17 million | Q3 2019: $22.55 million | Q1 2020: $20.93 million | Q2 2020: $15.07 million | Q3 2020: $14.84 million | Q1 2021: $26.15 million | Q2 2021: $26.41 million | Q3 2021: $25.22 million | Q1 2022: $34.37 million | Q2 2022: $29.03 million | Q3 2022: $53.38 million | Q1 2023: $41.42 million | Q2 2023: $35.01 million | Q3 2023: $28.80 million | Q1 2024: $35.36 million | Q2 2024: $18.24 million | Q3 2024: $13.89 million | Q4 2024: $20.02 million | Q1 2025: $13.63 million | Q2 2025: $9.38 million | Q3 2025: $6.80 million.
- Over the full 12 years of available data (2013 to 2024), Clearside Biomedical, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 948.7%.
- Historical annual values: Fiscal year 2024: $20.02 million | Fiscal year 2023: $28.92 million | Fiscal year 2022: $48.26 million | Fiscal year 2021: $30.44 million | Fiscal year 2020: $17.29 million | Fiscal year 2019: $22.60 million | Fiscal year 2018: $8.04 million | Fiscal year 2017: $9.22 million | Fiscal year 2016: $34.82 million | Fiscal year 2015: $20.28 million | Fiscal year 2014: $8.27 million | Fiscal year 2013: $1.91 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: